Posted by Michael Wonder on 07 Jun 2022
Sifi announces EMA validation of its marketing authorisation application for Akantior for the treatment of acanthamoeba keratitis
7 June 2022 - Sifi has launched an early access program across European countries in June 2022.
Sifi announced today that the EMA has validated its marketing authorisation application for Akantior (polihexanide) for the treatment of acanthamoeba keratitis.
